Author:
Guthrie Bruce,Clark Stella A.,Reynish Emma L.,McCowan Colin,Morales Daniel R.
Publisher
Public Library of Science (PLoS)
Reference33 articles.
1. Impact of FDA Drug Risk Communications on Health Care Utilization and Health Behaviors: A Systematic Review;S Dusetzina;Medical Care,2012
2. Prescribing of Rosiglitazone and Pioglitazone Following Safety Signals: Analysis of Trends in Dispensing Patterns in the Netherlands from 1998 to 2008;R Ruiter;Drug Saf,2012
3. Committee on Safety of Medicines (2004) Summary of clinical trial data on cerebrovascular adverse events (CVAEs) in randomized clinical trials of risperidone conducted in patients with dementia. London: Committee on Safety of Medicines.
4. NHS National Prescribing Centre (2009) Important updates on drug safety from the MHRA/CHM.
5. Committee for Medicinal Products for Human Use (2008) Opinion of the Committee for Medicinal Products for Human Use pursuant to article 5(3) of regulation (EC) No 726/2004 on conventional antipsychotics. Brussels: European Medicines Agency.
Cited by
37 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献